Welcome to our dedicated page for Legacy Education news (Ticker: LGCY), a resource for investors and traders seeking the latest updates and insights on Legacy Education stock.
Legacy Education Inc. (NYSE American: LGCY) is a for-profit, nationally accredited post-secondary education company that focuses on career-focused education and training, primarily in the healthcare field. The news and press releases about Legacy Education highlight its role as a provider of certificates and degrees in areas such as nursing, sonography, medical technicians, dental assisting, business administration, and other career-oriented disciplines.
On this news page, readers can review company-issued updates that cover financial and operating results, program approvals, accreditations, governance developments, and investor events. Legacy Education frequently announces quarterly and annual results, referencing trends in revenue, enrollment, new student starts, and student population. These releases provide context on how the company’s focus on healthcare education and program expansion relates to its reported performance.
News items also describe approvals for new allied health and imaging programs at institutions such as High Desert Medical College and Central Coast College, as well as national accreditation milestones for nursing programs at Integrity College of Health. Governance and leadership updates, including the appointment of new board members with experience in clinical medicine, financial innovation, and healthcare career education, are disclosed through press releases and related SEC filings.
In addition, Legacy Education issues announcements about participation in investor conferences and schedules for earnings conference calls, giving investors and other stakeholders insight into upcoming presentations and discussions about the company. This page aggregates such company communications so that users can follow Legacy Education’s reported developments in healthcare education, program accreditation, enrollment trends, and corporate governance over time.
Legacy Education (NYSE American: LGCY), a leading provider of career-focused education and training, has announced its participation in the 37th Annual ROTH Conference. The event will take place from March 16-18, 2025, at The Laguna Cliffs Marriott in Dana Point, California.
CEO LeeAnn Rohmann and CFO Brandon Pope will be available for one-on-one and small group meetings with institutional investors throughout the conference. Management will provide a company overview during these meetings. The conference serves as a platform for growth-oriented companies to connect with investors and industry leaders.
Legacy Education Inc. (NYSE: LGCY) reported strong financial results for Q2 FY2025. Revenue increased 29.2% to $13.6 million, with net income reaching $1.4 million and diluted EPS of $0.10. The company's student population grew 44.8% to 2,768, including students from the recently acquired Contra Costa Medical Career College.
For the six months ended December 31, 2024, revenue grew 32.1% to $27.6 million, with net income of $3.5 million and diluted EPS of $0.29. New student starts increased 16.2% during this period. The company's financial position shows $16.9 million in cash and cash equivalents, with total assets of $62.1 million.
The acquisition of Contra Costa Medical Career College, completed on December 18, contributed 389 students and is expected to show full financial impact in upcoming quarters. The company has surpassed 3,000 enrolled students as of January 31, 2025, marking a significant milestone in its growth strategy.
Legacy Education (NYSE American: LGCY) has announced its upcoming second quarter fiscal year 2025 earnings conference call, scheduled for Thursday, February 13, 2025, at 4:30 p.m. Eastern time. The company will release its financial results by 4:05 p.m. Eastern time on the same day.
Investors can access the live webcast through the investor relations section of Legacy Education's website. Participants may also join via teleconference by registering for the Q2 FY 2025 earnings call. Registration is recommended one day in advance or at least 15 minutes before the call begins. The webcast recording will remain accessible for 90 days on the company's website.
Legacy Education Inc. (NYSE American: LGCY) has announced its upcoming second quarter fiscal year 2025 earnings conference call, scheduled for Thursday, February 13, 2025, at 4:30 p.m. Eastern time. The company will release its financial results by 4:05 p.m. Eastern time on the same day.
Investors can access the live webcast through the investor relations section of www.legacyed.com. Participants may register for the teleconference at 'Q2 FY 2025 Legacy Education Inc. Earnings Conference Call.' The toll-free dial-in number is 877-407-9785, and the international dial-in number is +1-201-689-8843. Participants are advised to register one day in advance or at least 15 minutes before the call begins. An archived version of the webcast will remain accessible for 90 days on the company's website.
Legacy Education (NYSE: LGCY) has completed the acquisition of Contra Costa Medical Career College (CCMCC) in Antioch, California for $8 million. The purchase terms include: $6.13 million paid at closing, a $400,000 promissory note, and 118,906 shares of common stock valued at $1 million.
The acquisition expands Legacy Education's presence to six campuses across California, strengthening its allied health education offerings in Northern California. CCMCC provides healthcare training programs including Surgical Technology, Vocational Nursing, and Sonography. This strategic move aims to address the growing demand for healthcare professionals while expanding educational access in the industry.
Legacy Education (NYSE: LGCY) reported strong Q1 fiscal 2025 results with revenue growing 35.1% to $14.0 million. The company saw significant growth in key metrics, including a 23.3% increase in new student starts and a 25.4% rise in student population to 2,539. Financial highlights include EBITDA of $2.7 million, adjusted EBITDA of $2.8 million, and net income of $2.1 million, resulting in diluted earnings per share of $0.21. The growth was primarily driven by increased enrollment and expansion into higher-earning programs.
Legacy Education (NYSE American: LGCY) has announced its upcoming Q1 fiscal 2025 earnings conference call scheduled for November 14, 2024, at 4:30 p.m. Eastern time. The company will release its financial results prior to 4:00 p.m. on the same day. Investors can access the live webcast through the company's website at www.legacyed.com. Participants can join via teleconference with toll-free number 1-877-407-9785 or international number 1-201-689-8843. Registration should be completed at least 15 minutes before the call. The webcast recording will be available for 90 days.
Legacy Education (NYSE American: LGCY) has entered into an $8 million asset purchase agreement to acquire Contra Costa Medical Career College in Antioch, California. The purchase structure includes $6.6 million at closing, a $400,000 promissory note, and $1 million in Legacy Education shares. The acquisition target serves over 500 students with 14 allied health programs. This strategic move will expand Legacy's program portfolio, adding surgical technology and sterile processing programs, while increasing its California campus count from five to six.
Legacy Education Inc. (NYSE American: LGCY) reported strong financial results for Q4 and full year 2024. Revenue grew 34.1% to $12.8 million in Q4 and 29.7% to $46.0 million for the full year. New student starts increased 27.1% in Q4 and 21.8% for the year. The company achieved net income of $1.0 million in Q4 and $5.1 million for the year, with earnings per share of $0.10 and $0.55 respectively. EBITDA for the year was $6.5 million, with adjusted EBITDA of $8.4 million. The student population grew 28.3% to 2,187. CEO LeeAnn Rohmann attributed the growth to strategic initiatives and focus on high-quality education. The company expects continued growth and expansion in 2024.
Legacy Education Inc. (NYSE American: LGCY) has successfully closed its initial public offering (IPO) of 2,875,000 shares of common stock, including the full exercise of the underwriters' over-allotment option. The shares were priced at $4.00 per share, resulting in aggregate gross proceeds of $11.5 million before deducting underwriting discounts and offering expenses.
The company's shares began trading on the NYSE American on September 26, 2024, under the symbol 'LGCY'. Northland Securities, Inc. acted as the sole book-running manager for the offering, while Ladenburg Thalmann served as the lead manager. The Registration Statement on Form S-1 (File No. 333-281586) related to the offering was declared effective by the SEC on September 25, 2024.